Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Bosset

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy GroupJ F Bosset, J J Pavy, H P Hamers, et al.
Annals of Surgery|November 1, 1988
Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)A Gérard, M Buyse, B Nordlinger, et al.
Annales De Chirurgie|January 1, 1989
[Adjuvant radiochemotherapy in operable cancers of the thoracic esophagus. Preliminary results of a multicenter study. A study of 119 cases]M Gignoux, J F Bosset, B Apoil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2014
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II studyC Borg, T André, G Mantion, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1993
Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapyR O Mirimanoff, M Sinzig, M Krüger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2001
Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy GroupJ F Bosset, J C Horiot, H P Hamers, et al.
Human Genetics|September 10, 1999
Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancerQ Wang, C Lasset, F Desseigne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 25, 2006
[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities]A Toledano, P Garaud, D Serin, et al.
Oncoimmunology|February 6, 2018
Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC studyC Mirjolet, C Charon-Barra, S Ladoire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup studyA de Gramont, J F Bosset, C Milan, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy GroupJ F Bosset, J J Pavy, H P Hamers, et al.
Annals of Surgery|November 1, 1988
Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)A Gérard, M Buyse, B Nordlinger, et al.
Annales De Chirurgie|January 1, 1989
[Adjuvant radiochemotherapy in operable cancers of the thoracic esophagus. Preliminary results of a multicenter study. A study of 119 cases]M Gignoux, J F Bosset, B Apoil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2014
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II studyC Borg, T André, G Mantion, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1993
Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapyR O Mirimanoff, M Sinzig, M Krüger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2001
Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy GroupJ F Bosset, J C Horiot, H P Hamers, et al.
Human Genetics|September 10, 1999
Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancerQ Wang, C Lasset, F Desseigne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 25, 2006
[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities]A Toledano, P Garaud, D Serin, et al.
Oncoimmunology|February 6, 2018
Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC studyC Mirjolet, C Charon-Barra, S Ladoire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup studyA de Gramont, J F Bosset, C Milan, et al.
Pageof 9